YTHDF2 and colorectal carcinoma: The present results provide a detailed understanding of the relationship between miRNAs, RNA methylation, the Wnt/β‐catenin pathway and CRC progression, and identify miR‐6125 and YTHDF2 as potential targets for the clinical treatment of CRC.